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Abstract
Introduction
Although colorectal cancer mortality rates in the gener-
al U.S. population declined slightly from 1992 to 2000, the
rates for Hispanic men and women did not. Disparity in
colorectal cancer screening among Hispanics may be an
important factor in the unchanged mortality trends. This
study examined rates of colorectal cancer test use among
Hispanic and non-Hispanic adults in the United States.
Methods
Using sampling weights and logistic regression, we ana-
lyzed colorectal cancer test use among 5680 Hispanic and
104,733 non-Hispanic adults aged 50 years and older who
participated in the 2002 Behavioral Risk Factor
Surveillance System. We estimated the percentages and
adjusted odds ratios (ORs) of the respondents’ reported
test use by sociodemographic characteristics, health care
access, and state or territory of residence.
Results
Hispanic respondents aged 50 and older reported hav-
ing had either a fecal occult blood test within the past year
or a lower endoscopy (sigmoidoscopy or colonoscopy) with-
in 10 years less frequently (41.9%) than non-Hispanic
respondents  (55.2%). Rates of test use were lower for
respondents who reported less education, lower income, no
health insurance, and no usual source of health care,
regardless of Hispanic ethnicity. After adjusting for differ-
ences in education, income, insurance, and having a usual
source of health care, Hispanic respondents remained less
likely than non-Hispanic respondents to report colorectal
cancer testing (OR for fecal occult blood test, 0.66; 95% con-
fidence interval [CI], 0.56–0.81; OR for lower endoscopy,
0.87; 95% CI, 0.77–0.99). Greater disparity in screening
rates between Hispanics and non-Hispanics was observed
in Colorado, California, and Texas than in other states.
Conclusion
A disparity exists between Hispanic and non-Hispanic
U.S. adults in colorectal cancer test use. This disparity
varies among the states, highlighting the diverse health
care experience of Hispanic adults in the United States.
Introduction
Colorectal cancer is a leading cause of cancer-related
death in the United States (1). Although Hispanic men and
women have lower incidence and mortality rates from col-
orectal cancer than non-Hispanics, colorectal cancer
remains the second leading cause of cancer-related mortal-
ity among Hispanic men and third leading cause among
Hispanic women (2). In 2003, 7000 new cases and 2300
deaths from colorectal cancer were expected among
Hispanic men and women (2). Mortality rates among
Hispanic individuals did not significantly decline from
1992 to 2000 despite reductions among non-Hispanic white
and black men and women (3). Disparity in colorectal can-
cer screening among Hispanics may be an important factor
in the unchanged mortality trends. Previous studies have
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shown that colorectal cancer screening rates are lower for
Hispanic populations (4-8) and that Hispanic men and
women are less likely to be diagnosed at an earlier stage
than non-Hispanic whites (2).
Recommendations for colorectal cancer screening are
that men and women of average risk begin regular screen-
ing at age 50 with one of the following: 1) an annual fecal
occult blood test (FOBT), 2) a flexible sigmoidoscopy every
5 years, 3) a combination of FOBT annually with flexible
sigmoidoscopy every 5 years, 4) a colonoscopy every 10
years, or 5) a double-contrast barium enema every 5 years
(9-11). Supporting evidence for these screening tests is
summarized in the recommendations from the United
States Preventive Services Task Force (USPSTF) (12).
Early detection and removal of precancerous polyps has
been proven to prevent colorectal cancer incidence (13,14)
and mortality (15). Several randomized controlled trials
have demonstrated decreased colorectal cancer incidence
(16) and mortality (17-19) through regular FOBT, and
case-control studies have demonstrated the efficacy of sig-
moidoscopy (20,21) and colonoscopy (13). Despite the effec-
tiveness of screening, overall screening rates are low (22).
Identifying disparities in colorectal cancer testing
among Hispanics could be useful in focusing interven-
tions to reduce cancer mortality. The U.S. Hispanic pop-
ulation, representing 12.5% of the U.S. population, is
heterogeneous, with each state having a unique compo-
sition of Hispanic subgroups and other demographic
characteristics (23). Previous studies have examined col-
orectal cancer screening rates for Hispanic populations
nationally (4-8) or within specific communities (24-28).
However, comparisons of the results across communities
are limited by differences in study design and questions
(29). The Behavioral Risk Factor Surveillance System
(BRFSS) is a national population-based survey of health
behaviors designed with a standardized format to allow
for state-based comparisons. A comparative analysis of col-
orectal cancer test use by Hispanic ethnicity across the
United States and among states with large Hispanic pop-
ulations has not been done previously.
We analyzed data from the 2002 BRFSS to estimate
Hispanic-specific rates for receiving colorectal cancer tests.
We determined national percentages and odds ratios (ORs)
of Hispanic and non-Hispanic adults who reported having
had colorectal cancer testing within recommended screen-
ing periods. We then examined state-specific test use rates
among Hispanic adults in Puerto Rico and nine states that
administered the survey in Spanish and had an adequate
number of Hispanic respondents. Finally, to explore ethnic
disparities within these states, we examined differences in
the percentage of reported colorectal cancer test use
between Hispanic and non-Hispanic respondents.
Methods
The BRFSS is a national standardized, continuous
random-digit–dial telephone survey begun in 1984 to mon-
itor the behavioral risk factors associated with mortality
and morbidity (30,31). The BRFSS is supported by the
Centers for Disease Control and Prevention and conducted
by all states, the District of Columbia, and three territo-
ries. The study population for the BRFSS includes civilian,
noninstitutionalized adults aged 18 years and older with
telephones. For the 2002 BRFSS, the median response
rate, calculated according to procedures recommended by
the Council of American Survey Research Organizations
(CASRO) (32), was 58.3% (ranging from 42.2% in New
Jersey to 82.6% in Minnesota). Poststratification weights
by age, race, and sex of the state population account for the
coverage of nonrespondents or ineligible households.
Respondents aged 50 years and older were asked ques-
tions about the use of tests that screen for colorectal can-
cer. Background knowledge of whether the respondent
“ever heard of” the specific test was not assessed before
asking about test use. The use of an FOBT was determined
by asking, “A blood stool test is a test that may use a spe-
cial kit at home to determine whether the stool contains
blood. Have you ever had this test using a home kit?” If the
respondent answered yes, the question was followed by,
“How long has it been since you had your last blood test
using a home kit?” Similarly, for sigmoidoscopy and
colonoscopy, respondents were asked, “Sigmoidoscopy and
colonoscopy are exams in which a tube is inserted in the
rectum to view the bowel for signs of cancer or other health
problems. Have you ever had either of these exams?” and
“How long has it been since you had your last sigmoi-
doscopy or colonoscopy?”
Both sigmoidoscopy and colonoscopy are procedures that
involve using a flexible, fiber-optic instrument (endoscope)
to view the rectum and colon for abnormalities.
Colonoscopy examines the entire colon, whereas sigmoi-
doscopy focuses on the lower third of the colon. In this
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endoscopy. BRFSS questions do not differentiate between
sigmoidoscopy and colonoscopy. The recommended screen-
ing interval is every 10 years for colonoscopy and every 5
years for sigmoidoscopy; we defined reported use of lower
endoscopy within the past 10 years as “within the recom-
mended interval.” Although the FOBT and lower
endoscopy are tests that are commonly recommended for
colorectal cancer screening (11), the BRFSS does not dis-
tinguish between testing used for screening and testing
used for diagnostic purposes; therefore, we use the terms
colorectal cancer testing and test use rather than screening.
Hispanic individuals are defined by the U.S. Census
Bureau as individuals who indicate their origin as Mexican,
Puerto Rican, Cuban, Central or South American, or other
Hispanic origin (23). For the BRFSS, Hispanic ethnicity
was determined by the question, “Are you Hispanic or
Latino?” followed by questions about race. Because
Hispanic ethnicity and race were separate questions, indi-
viduals reporting Hispanic ethnicity could be of any race.
The BRFSS survey did not ask respondents to identify their
Hispanic subgroup. Additional BRFSS variables used for
this study include sex, age, highest grade of school 
completed (education), annual household income (income),
having any kind of health care coverage (insurance), and
having a personal doctor or health care provider (usual
source of health care). All responses were self-reported.
The total number of 2002 BRFSS respondents aged 50
years and older in all states, territories, and the District of
Columbia was 111,036. Of these respondents, 5680 identi-
fied themselves as Hispanic. Respondents who answered
“Don’t know/Not sure” or “Refused” to ever having had an
FOBT (1.6%) or lower endoscopy (2.1%) were excluded. In
addition, 1.2% of respondents were excluded because they
were unsure or refused to answer questions about
Hispanic ethnicity, education, insurance status, and usual
source of care.
Statistical estimates were produced using SAS 8.02
(SAS Institute Inc, Cary, NC) and SUDAAN 7.5.3
(Research Triangle Institute, Research Triangle Park,
NC). All data were weighted by age, sex, and race to
reflect the population of each state. Percentages and 95%
confidence intervals (CIs) were age-adjusted using 5-year
age groups to standardize to the 2000 U.S. census. Using
logistic regression, we calculated crude ORs and CIs for
receiving recommended colorectal cancer testing, then
adjusted the ORs for age, sex, race, Hispanic ethnicity,
education, insurance, income, and having a usual source of
care. The respondents who chose not to give information on
income were grouped into an “unknown” category to be
included in the logistic regression.
The state-specific analysis was limited to states and ter-
ritories where the survey was administered in both
Spanish and English and where there were at least 100
Hispanic respondents aged 50 or older. These states and
territories were Arizona, California, Colorado, Florida,
Massachusetts, New Jersey, New Mexico, New York,
Puerto Rico, and Texas. Of the 5680 respondents who
reported Hispanic ethnicity, 3808 (67%) lived in one of the
included states. It was not possible to determine from
national BRFSS survey data which language was used
during the interview (33). Therefore, we could not sepa-
rately analyze surveys completed in Spanish and surveys
completed in English.
Results
Colorectal cancer test use by Hispanic ethnicity
Among both Hispanic and non-Hispanic respondents, a
higher percentage of respondents reported having had a
lower endoscopy test than having had an FOBT ever and
within the recommended screening intervals (Table 1). The
estimated percentage of Hispanic respondents aged 50 and
older who reported having had an FOBT within the past
year was significantly lower (12.5%) than for non-Hispanic
respondents (22.3%). This finding was also true for lower
endoscopy within 10 years (36.2% for Hispanics compared
with 45.9% for non-Hispanics) or either test within recom-
mended intervals (41.9% for Hispanics compared with
55.2% for non-Hispanics).
Sociodemographic characteristics and health care access
A higher percentage of non-Hispanic men than women
reported having received colorectal cancer testing, where-
as there was no difference by sex observed for Hispanic
respondents (Table 2). For non-Hispanics, FOBT or lower
endoscopy test use increased by 10-year age groups then
declined after age 80. For Hispanic respondents, reported
use of FOBT increased with each 10-year age group until
80 years then declined, whereas use of lower endoscopy
continued to increase in each age group without decline.
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Both non-Hispanic and Hispanic respondents who
reported more education and a higher household income
reported higher percentages of having had either an FOBT
within 1 year or lower endoscopy within 10 years. Of note,
the difference in the percentages of non-Hispanic and
Hispanic respondents who reported lower endoscopy with-
in 10 years was smallest among respondents in the high-
est income category. Respondents without insurance or
without a usual source of care had the lowest percentage of
reported colorectal cancer test use, regardless of ethnicity.
Because of the small number of Hispanic respondents who
were uninsured, the percentage for FOBT use within 1
year among this group could not be reported. The small
number of respondents would lead to an unstable estimate.
Among non-Hispanic respondents who reported no insur-
ance and no usual source of care, the percentage of use of
either colorectal cancer test within recommended intervals
was 34.7% (data not shown).
Crude and adjusted ORs
Table 3 presents the adjusted ORs and CIs from a logis-
tic regression analysis of having reported receiving an
FOBT within the past year or a lower endoscopy within 10
years by ethnicity, education, insurance, and usual source
of care. Crude ORs showed that respondents who reported
less education, no health insurance, or no usual source of
care were less likely to report receiving appropriate col-
orectal cancer testing for FOBT and lower endoscopy (data
not shown). When adjusted to account for age, sex, race,
education, income, insurance, and having a usual source of
care, Hispanic respondents remained less likely than non-
Hispanic respondents to report having had either test
within recommended screening intervals.
Variations in colorectal cancer test use among Hispanic
respondents
The percentage of Hispanic respondents aged 50 and
older who reported an FOBT within the past year ranged
from 8.5% in Texas to 24.1% in Massachusetts, and the
percentage of Hispanic respondents who reported a lower
endoscopy within the past 10 years ranged from 28.9% in
Colorado to 47.1% in Massachusetts (Table 4). For receiv-
ing either test within the recommended period, Hispanic
respondents in the Northeastern states (Massachusetts,
New Jersey, and New York) had higher testing rates than
Hispanic respondents in the Western states (Arizona,
California, Colorado, and New Mexico). In Arizona, the
higher rates of overall reported test use (47.1%) is likely
due to higher reported use of the FOBT. Among respon-
dents living in Puerto Rico, such a small number reported
ever having had an FOBT that a reliable estimate could
not be given.
The Figure compares the percentages of respondents
who reported receiving either an FOBT or a lower
endoscopy within recommended screening intervals by
Hispanic ethnicity. Percentages of Hispanic men and
women who received recommended testing were generally
lower than those of non-Hispanic individuals in each state
evaluated, except for Massachusetts, where rates were
similar. In contrast, there is a notably larger disparity
between Hispanic and non-Hispanic groups in Colorado,
California, and Texas than in the other states.
Discussion
The results of this study confirm that, regardless of
ethnicity, colorectal cancer test use among men and
women aged 50 years and older is low compared with other
well-known cancer screening tests (4-6,34). We estimate
that 42% of Hispanic respondents reported having had the
recommended colorectal cancer testing compared with 55%
of non-Hispanic respondents. This finding of lower
screening rates for Hispanic men and women than for
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Figure. Age-adjusted percentage of Hispanic and non-Hispanic adults aged
50 years and older in selected states who reported receiving colorectal can-
cer screening (fecal occult blood test within past year, lower endoscopy
within 10 years, or both) as recommended, Behavioral Risk Factor
Surveillance System, 2002. Lines within bars represent 95% confidence
intervals. Puerto Rico had too few non-Hispanic respondents to include in
the comparison.non-Hispanic men and women is consistent with other
studies (4-8,24-26,34,35). Despite the relation of educa-
tion, income, insurance, and a usual source of care to
reported test use, adjusting for these factors does not
fully account for the lower percentage of reported col-
orectal cancer test use among Hispanics. The adjusted
analysis suggests that there are factors beyond health
care access that prevent Hispanic men and women from
receiving colorectal cancer tests.
This study also shows that Hispanic colorectal cancer
test use differs among states. Colorado, California, and
Texas had low percentages of Hispanic respondents report-
ing recommended test use and a greater disparity in col-
orectal cancer testing between Hispanic and non-Hispanic
respondents than other states. In Massachusetts and New
Jersey, test use among Hispanic men and women was
higher than other states, and the disparity between
Hispanic and non-Hispanic respondents was less. For
states that had too few Hispanic BRFSS respondents for
this analysis, colorectal test use and disparities are
unknown. Often, Hispanic populations are analyzed as a
single group, and these state-specific differences are not
apparent. In addition to variation among states, there may
be variation within each state as well. For example,
Coughlin et al suggested that Hispanic women living in
counties along the U.S.–Mexico border, regardless of their
state of residence, were less likely to receive breast and
cervical cancer screening than Hispanic women in nonbor-
der counties (36).
A factor that may account for state differences is the
unique composition and culture of Hispanic subgroups in
each state. In general, the Western states have an overall
higher Hispanic proportion of the population and, in the
Western United States, Hispanic individuals are more
likely to be of Mexican descent than they are in the
Northeast, which has Puerto Rican, South American, and
Central American populations (23). Hispanic subgroups
could not be reflected in this analysis because BRFSS
respondents who reported Hispanic ethnicity were not
asked to report their subgroup. However, a recent study of
the 2000 National Health Interview Survey (NHIS) ana-
lyzed cancer screening among Latino subgroups. Similar to
our results, Sheinfeld Gorin and Heck found that FOBT
use among Hispanic populations was low (14%) (37). In the
subgroup study, a higher percentage of Mexican and
Puerto Rican respondents (15%–22%) reported FOBT use
than Cuban, Dominican, Central American, or South
American respondents (9%–11%) (37). The same study
showed endoscopy use within 5 years was highest among
Cuban respondents (25%) and lowest among Dominicans,
Central Americans, and South Americans (14%) (37). Our
finding that screening rates are lower in the Western
states, where the predominate Hispanic subgroup is
Mexican, contrasts with the NHIS findings that Mexican
respondents were more likely to have an endoscopy within
the past 5 years.
Understanding the individual influences of ethnicity,
socioeconomic factors, and health care access on colorectal
cancer test use is challenging. Previous studies cite the
lack of a usual source of health care as the most consistent
reason that Hispanic individuals are not being screened for
colorectal and other cancers (38-40) and also indicate that
Hispanic men and women who receive other prevention
services are more likely to be screened regularly
(7,8,24,27). This study demonstrated that men and women
without a usual source of health care are less likely to
receive recommended colorectal cancer testing. However,
studies that have attempted to separate socioeconomic
factors and health care access from ethnicity in different
populations have had differing results. Two separate stud-
ies in Washington State and the San Francisco Bay area
reported that fewer Hispanic men and women reported
receiving colorectal cancer tests than non-Hispanic indi-
viduals, but the differences disappeared when they
adjusted for health care access and education (24,28). In
contrast, a study in Texas reported that Hispanic women
were less likely than non-Hispanic women to have ever
received colorectal cancer screening by FOBT after adjust-
ing for similar socioeconomic factors (41). Our findings,
which represent a larger, national population, support the
latter study that Hispanic men and women remain less
likely to be screened despite education, income, and
health care access.
The BRFSS survey did not ask whether Hispanic
respondents were born outside of the United States and, if
so, time since immigration to the United States.
Therefore, we were not able to assess the role of accultur-
ation and language of BRFSS respondents in this study.
Analyses of other national health behaviors surveys have
shown acculturation to be associated with reduced col-
orectal cancer rates (7). However, the effect of accultura-
tion and language on screening for cervical and breast
cancer has not always been shown to be as significant as
access factors (8,42).
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There were several limitations to this study. Actual com-
pliance with screening guidelines may be lower than per-
centages reported in this article. In our study, to fully cap-
ture the use of colonoscopy, having a lower endoscopy
(which refers to both sigmoidoscopy and colonoscopy)
“within 10 years” is considered to be within recommended
screening intervals. With this definition, individuals who
received sigmoidoscopy outside the recommended 5-year
screening interval but within 10 years were considered
compliant with screening guidelines. In addition, there
was no way to differentiate between tests done for screen-
ing purposes and tests performed for diagnostic purposes.
Also, the use of a double-contrast barium enema, an
acceptable but less often recommended choice (43), was not
available from the BRFSS survey. Comparisons of the
rates in this report with other colorectal cancer screening
studies must be made with caution because the time
frame used for having received screening varies (29);
some studies have examined whether respondents have
ever been tested, while other studies have asked respon-
dents about tests administered within the time frame of
screening guidelines.
Telephone survey data are limited by several factors.
The response rate to the 2002 BRFSS was 58%. Low
response rates may bias results by selecting a unique pop-
ulation that differs from the general population in health
care access, use, and beliefs. Despite this low response
rate, BRFSS data have been shown to be valid and reliable
when compared with other national surveys, and bias in
demographic characteristics of respondents in BRFSS data
was not associated with response rate (44). Additionally,
the BRFSS excludes individuals who do not have house-
hold telephones and households that use a cellular phone
exclusively. Low-income Hispanic households are less like-
ly to own telephones than other low-income households
(45) and may be underrepresented. Some Hispanic respon-
dents may have experienced linguistic barriers to under-
standing the survey questions or may have answered the
questions without having been familiar with the colorectal
cancer tests. The U.S. Census Bureau estimates that more
than one third of the more than 21 million people aged 18
and older who speak Spanish at home reported that they
spoke English “not well” or “not at all” (46).
Responses were self-reported. The BRFSS questions did
not ascertain whether the respondents had “ever heard of”
the colorectal cancer test of interest. Despite previous stud-
ies, which have shown moderate and good concordance
between self-reported colorectal cancer testing when
validated with medical records (47,48), cognitive testing
has shown that respondents have difficulty comprehend-
ing colorectal cancer questions because they often do not
recognize or understand particular colorectal cancer
tests (49). In this study, the responses were not validat-
ed, and respondents may not have been familiar with the
test, may have felt a positive response was socially desir-
able, or both (29).
Colorectal cancer test use is estimated to be lower among
Hispanic than non-Hispanic adults. Differences in test use
cannot be fully explained by education, income, and health
care access because, after adjusting for these factors,
Hispanic men and women remain less likely to report hav-
ing had colorectal cancer testing at recommended inter-
vals. Certain Western states had a large disparity between
the percentages of Hispanic and non-Hispanic test use,
whereas Northeastern states had similar percentages of
use. Regardless of the differing degrees of disparities,
increasing awareness of and access to colorectal cancer
screening among Hispanics is needed. The differences in
colorectal cancer test use among states call attention to the
diverse health care experience of Hispanic adults in the
United States. Future studies that explore the reasons for
differences in test use among Hispanic communities may
highlight effective programs and practices that encourage
increased screening.
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Tables
Table 1. Percentagea of Respondents Aged 50 Years and Older (N = 110,413) Who Reported Receiving Colorectal Cancer
Tests, Ever and Within Recommended Screening Periods, by Test Type, Behavioral Risk Factor Surveillance System, 2002
FOBTc ever 45.1 (44.6-45.6) 47.2 (46.7-47.7) 21.7 (19.3-24.1)
Lower endoscopy ever 49.2 (48.7-49.7) 50.1 (49.6-50.6) 39.9 (37.1-42.7)
FOBT or lower endoscopy ever 65.8 (65.3-66.3) 67.4 (66.9-67.9) 49.0 (46.2-51.8)
FOBT within last year 21.5 (21.1-21.9) 22.3 (21.9-22.7) 12.5 (10.4-14.6)
Lower endoscopy within 10 years 45.0 (44.5-45.5) 45.9 (45.4-46.4) 36.2 (33.4-39.0)
FOBT within last year or lower endoscopy within 10 years 54.0 (53.5-54.5) 55.2 (54.7-55.7) 41.9 (39.0-44.8)
aAge-adjusted to the 2000 U.S. census.
bCI indicates confidence interval.
cFOBT indicates fecal occult blood test.
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Table 2. Percentagea of Non-Hispanic and Hispanic Respondents Aged 50 Years and Older (N = 110,413) Who Reported
Receiving Colorectal Cancer Tests Within Recommended Screening Intervals, Behavioral Risk Factor Surveillance System,
2002
Total 104,733 5680 22.3 (21.9-22.7) 12.5 (10.4-14.6) 45.9 (45.5-46.4) 36.2 (33.4-39.0)
Sex
Male 40,325 2153 23.4 (22.7-24.1) 13.8 (10.1-17.5) 47.8 (47.0-48.6) 35.3 (31.0-39.6)
Female 64,408 3527 21.6 (21.1-22.1) 11.7 (9.4-14.0) 44.5 (43.8-45.2) 37.2 (33.6-40.8)
Age, y
50–59 41,155 2459 18.1 (17.5-18.7) 9.8 (7.5-12.1) 37.2 (36.4-38.0) 25.3 (21.9-28.7)
60–69 29,150 1731 24.7 (23.8-25.6) 13.5 (10.5-16.5) 49.7 (48.7-50.7) 37.7 (33.0-42.4)
70–79 23,449 1106 27.4 (26.4-28.4) 16.0 (9.5-22.5) 55.5 (54.4-56.6) 46.9 (38.9-54.9)
≥80 10,979 384 22.4 (21.1-23.7) 13.1 (5.8-20.4) 49.4 (47.7-51.1) 50.5 (40.1-60.9)
Education
<High school 14,422 2242 16.8 (15.6-18.0) 6.4 (4.3-8.5) 34.7 (33.2-36.2) 30.2 (26.0-34.4)
High school graduate 35,081 1645 21.1 (20.4-21.8) 18.2 (13.2-23.2) 42.0 (41.1-42.9) 36.5 (31.9-41.1)
>High school 54,951 1774 24.4 (23.8-25.0) 17.3 (13.4-21.2) 51.0 (50.3-51.7) 45.1 (40.3-49.9)
Annual household income, $
<20,000 2,176 2650 19.2 (18.2-20.2) 6.5 (4.7-8.3) 36.7 (35.5-37.9) 32.0 (28.1-35.9)
20,000–34,999 23,114 1097 21.1 (20.3-21.9) 17.7 (12.3-23.1) 42.1 (41.0-43.2) 39.6 (33.8-45.4)
35,000–74,999 23,916 849 23.5(22.6-24.4) 22.8 (15.8-29.8) 50.0 (48.9-51.1) 37.2 (29.6-44.8)
>75,000 14,237 272 26.7 (25.1-28.3) 21.4 (13.3-29.5) 57.1 (55.3-58.9) 56.5 (47.4-65.6)
Insurance
Yes 96,838 4943 23.0 (22.5-23.5) 14.0 (11.7-16.3) 47.2 (46.7-47.7) 38.5 (35.5-41.5)
No 7,727 730 13.8 (11.9-15.7) —d 27.9 (25.5-30.3) 20.3 (13.5-27.1)
Usual source of health care
Yes 94,595 4792 23.5 (23.0-24.0) 14.3 (12.0-16.6) 47.9 (47.3-48.5) 40.4 (37.5-43.3)
No 9,915 880 10.5 (9.4-11.6) 6.5 (2.3-10.7) 26.8 (24.8-28.8) 21.5 (15.3-27.7)
aAge-adjusted to the 2000 U.S. census.
bFOBT indicates fecal occult blood test.
cCI indicates confidence interval.
dUnstable estimate (relative SE >30%).
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No. of Respondents FOBTb Within 1 Year Lower Endoscopy Within 10 Years
Non-Hispanic, Hispanic, Non-Hispanic, Hispanic,
Characteristic Non-Hispanic Hispanic % (95% CIc) % (95% CIc) % (95% CIc) % (95% CIc)Table 3. Adjusteda Odds Ratios (ORs) of Receiving Colorectal Cancer Tests, by Hispanic Ethnicity, Education, and Health Care
Access, Behavioral Risk Factor Surveillance System, 2002
Ethnicity
Non-Hispanic 1.00 (refd) 1.00 (refd)
Hispanic 0.66 (0.56-0.81) 0.87 (0.77-0.99)
Education
>High school 1.00 (ref) 1.00 (ref)
High school graduate 0.89 (0.83-0.94) 0.76 (0.73-0.80)
<High school 0.65 (0.60-0.72) 0.63 (0.58-0.68)
Insurance
Yes 1.00 (ref) 1.00 (ref)
No 0.63 (0.56-0.72) 0.63 (0.56-0.70)
Usual source of health care
Yes 1.00 (ref) 1.00 (ref)
No 0.41 (0.36-0.47) 0.43 (0.39-0.47)
aLogistic regression model included age, sex, race, Hispanic ethnicity, education, income, insurance, and having a usual source of health care.
bFOBT indicates fecal occult blood test.
cCI indicates confidence interval.
dRef indicates referent group.
Table 4. Percentagea of Hispanic Respondents Aged 50 Years and Older Who Reported Receiving Fecal Occult Blood Test
(FOBT), Lower Endoscopy, or Both Within Recommended Intervals, by Area and Test Type, Behavioral Risk Factor Surveillance
System, 2002
Northeast
Massachusetts 6.8 148 24.1 (16.3-31.9) 47.1 (38.5-55.7) 61.5 (52.8-70.2)
New York 15.1 103 16.7 (9.0-24.4) 37.3 (27.2-47.4) 49.5 (37.7-61.3)
New Jersey 13.3 110 13.6 (7.3-19.9) 41.8 (29.0-54.6) 51.4 (40.2-62.6)
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FOBTb Within Past Year  Lower Endoscopy Within 10 Years
Characteristic Adjusted OR (95% CIc) Adjusted OR (95% CIc)
FOBT Within 1 Year
Hispanic Ethnicity,  Lower Endoscopy  or Lower Endoscopy
% of U.S. Population  No. of Hispanic  FOBT Within 1 Year,  Within 10 Years,  Within 10 Years,
Area (2000 Census) Respondents % (95% CIb) % (95% CIb) % (95% CIb)
aAge-adjusted to 2000 U.S. census.
bCI indicates confidence interval.
cUnstable estimate (relative SE >30%).
(Continued on next page)VOLUME 3: NO. 2
APRIL 2006
South
Florida 16.8 196 17.2 (10.8-23.6) 41.5 (34.1-48.9) 46.7 (39.1-54.3)
Texas 32.0 334 8.5 (5.4-11.6) 31.2 (25.1-37.3) 38.2 (32.0-44.4)
West
Arizona 25.3 129 21.2 (12.6-29.8) 34.8 (26.3-43.3) 47.1 (37.8-56.4)
California 32.4 180 11.2 (5.3-17.1) 37.6 (29.6-45.6) 40.3 (32.1-48.5)
Colorado 17.1 135 15.8 (10.1-21.5) 28.9 (21.4-36.4) 35.7 (27.7-43.7)
New Mexico 42.1 600 13.6 (10.4-16.8) 36.4 (31.7-41.1) 43.6 (38.8-48.4)
Territory
Puerto Rico 98.8 1873 —c 30.0 (27.4-32.6) 30.3 (27.7-32.9)
aAge-adjusted to 2000 U.S. census.
bCI indicates confidence interval.
cUnstable estimate (relative SE >30%).
Table 4. (continued) Percentagea of Hispanic Respondents Aged 50 Years and Older Who Reported Receiving Fecal Occult
Blood Test (FOBT), Lower Endoscopy, or Both Within Recommended Intervals, by Area and Test Type, Behavioral Risk Factor
Surveillance System, 2002
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FOBT Within 1 Year
Hispanic Ethnicity,  Lower Endoscopy  or Lower Endoscopy
% of U.S. Population  No. of Hispanic  FOBT Within 1 Year,  Within 10 Years,  Within 10 Years,
Area (2000 Census) Respondents % (95% CIb) % (95% CIb) % (95% CIb)